Cart
sales@molnova.com
Longikaurin E
CAS No. 77949-42-9
Longikaurin E( (-)-Longikaurin E )
Catalog No. M27336 CAS No. 77949-42-9
Longikaurin E is a therapeutic agent for pancreatic cancer. It is isolated from Isodon adenolomus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 387 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLongikaurin E
-
NoteResearch use only, not for human use.
-
Brief DescriptionLongikaurin E is a therapeutic agent for pancreatic cancer. It is isolated from Isodon adenolomus.
-
DescriptionLongikaurin E is a therapeutic agent for pancreatic cancer. It is isolated from Isodon adenolomus.
-
In Vitro——
-
In Vivo——
-
Synonyms(-)-Longikaurin E
-
PathwayOthers
-
TargetOther Targets
-
RecptorFarnesyl transferase (FTase)|GGTase I
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number77949-42-9
-
Formula Weight390.476
-
Molecular FormulaC22H30O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12[C@@H](C[C@@H]3C[C@]1(C(=O)C3=C)[C@@]1(O)OC[C@]22CCCC(C)(C)[C@@]2([H])[C@@H]1O)OC(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kazi A, et al. Dual farnesyl and geranylgeranyl transferase inhibitor thwarts mutant KRAS-driven patient-derived pancreatic tumors. Clin Cancer Res. 2019 Jun 21.
molnova catalog
related products
-
TFMB-(R)-2-HG
TFMB-(R)-2-HG is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cell differentiation in response to estrogen withdrawal.
-
GPC3 (298 - 306), mo...
GPC3 (298 - 306), mouse
-
Cephalosporin C zinc...
Cephalosporin C zinc salt was a potent inhibitor of SAMHD1 (IC50 : 1.1 ± 0.1 μM) and this inhibition was largely attributable to the presence of zinc.?
